Our News

The Skinner Family - Living with Primary Hyperoxaluria Type 1

May 1, 2019

Alnylam Pharmaceuticals

Three of the four Skinner children have been diagnosed with primary hyperoxaluria type 1 (PH1), a rare, life-threatening disease that can cause irreparable damage to kidneys and other vital organs. Learn more about PH1 here.

The Skinner Family - Living with Primary Hyperoxaluria Type 1

 

Tags

Patient Focus, Videos, Primary Hyperoxaluria Type 1, PH1

Related Content See All News ›
Patient Focus First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR ...
Patient Focus The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disea ...
Patient Focus Building a Collaborative Framework for Facilitating Patient Access to Innovative Therap ...

Categories

Content Types

See All News ›
Related Content See All News ›
Patient Focus First Consensus Recommendations for Holistic Care of People Living With Hereditary ATTR ...
Patient Focus The Importance of Self-Advocacy: Supporting Patients and Caregivers in Their Rare Disea ...
Patient Focus Building a Collaborative Framework for Facilitating Patient Access to Innovative Therap ...
See All News ›

FOLLOW US

Visit our social channels to learn more about the innovative work we are doing at Alnylam.

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site